Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1999
08/31/1999US5945102 Crustacean and fish derived multifunctional enzyme
08/31/1999US5945097 Method for lowering cholesterol levels with interleukin-10
08/31/1999US5945096 Administering to the human for suppressing a human immune response to an antigen, an effective amount of antigen non-specific human glycosylation inhibiting factor
08/31/1999CA2218755C Monoclonal antibody to human beta 2 integrin alpha subunit
08/31/1999CA2183315C Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
08/31/1999CA2183314C Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
08/31/1999CA2125282C Pharmaceutically applicable nanosol and process for preparing the same
08/31/1999CA2033447C Synergistic combination for treating herpes infections
08/31/1999CA2006028C Cosmetic or pharmaceutical composition containing polymers or fatty bodies microspheres with at least one active ingredient
08/26/1999WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR
08/26/1999WO1999042597A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
08/26/1999WO1999042596A2 Phosphodiesterase 10
08/26/1999WO1999042593A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
08/26/1999WO1999042585A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
08/26/1999WO1999042584A1 Apoptosis inducing molecule ii and methods of use
08/26/1999WO1999042582A1 Ammaid, a g protein coupled receptor
08/26/1999WO1999042580A2 Gaba receptors and their uses
08/26/1999WO1999042579A2 Caf1-related protein
08/26/1999WO1999042578A2 Modulation of cell proliferation, methods and reagents
08/26/1999WO1999042577A2 Biotin-binding receptor molecules
08/26/1999WO1999042576A1 Cerebellin-2 related polypeptides and dna coding therefor
08/26/1999WO1999042575A2 Calcium-activated potassium channel beta subunit gene and protein
08/26/1999WO1999042574A1 Sequences of an ih ionic channel and the use thereof
08/26/1999WO1999042573A1 Immunological methods to modulate myostatin in vertebrate subjects
08/26/1999WO1999042570A1 Cellular flip compositions for treatment of arteriosclerotic disorders
08/26/1999WO1999042568A1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
08/26/1999WO1999042562A1 NOVEL pgsA
08/26/1999WO1999042486A1 Method of producing mouse and human endostatin
08/26/1999WO1999042485A1 Mucilage, a g-protein-coupled receptor
08/26/1999WO1999042484A1 Fishboy, a g-protein coupled receptor
08/26/1999WO1999042483A1 Agents for the prevention of damages caused by stress conditions
08/26/1999WO1999042482A1 Methods for treatment of diabetes using peptide analogues of insulin
08/26/1999WO1999042481A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF
08/26/1999WO1999042480A1 Analgesic peptides from venom of grammostola spatulata and use thereof
08/26/1999WO1999042478A2 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32
08/26/1999WO1999042477A2 Transporter protein for saccharide-coupled medicaments
08/26/1999WO1999042476A1 Novel antibacterial agents
08/26/1999WO1999042475A1 Azole peptidomimetics as thrombin receptor antagonists
08/26/1999WO1999042473A1 Inhibition of toxin translocation
08/26/1999WO1999042470A1 Secreted proteins and polynucleotides encoding them
08/26/1999WO1999042429A1 Antitumor agents
08/26/1999WO1999042137A2 Stress promoter control of therapeutic genes in gene therapy: compositions and methods
08/26/1999WO1999042133A1 Inhibitors of complement activation
08/26/1999WO1999042132A1 Use of anti-cd44 monoclonal antibody to enhance wound healing
08/26/1999WO1999042131A1 Skin care compositions
08/26/1999WO1999042129A1 Purified sperm surface antigen, monoclonal antibody therefor and application therefor
08/26/1999WO1999042127A2 Receptor derived peptides as modulators of receptor activity
08/26/1999WO1999042126A1 Recombinant fibronectin-based extracellular matrix for wound healing
08/26/1999WO1999042125A1 Pharmaceutical formulation of a didemnin compound
08/26/1999WO1999042124A1 Liquid crystal forms of cyclosporin
08/26/1999WO1999042123A1 Method of promoting neuronal cell proliferation and diffrentiation
08/26/1999WO1999042122A1 Method of promoting embryonic stem cell proliferation
08/26/1999WO1999042121A1 Modified heat shock protein-antigenic peptide complex
08/26/1999WO1999042119A1 Antimicrobial peptides and derived metapeptides
08/26/1999WO1999042118A2 Compounds and methods for diagnosis of tuberculosis
08/26/1999WO1999042117A1 Fibronectin peptides-based extracellular matrix for wound healing
08/26/1999WO1999042116A1 Novel disulfides and thiol compounds
08/26/1999WO1999042110A1 Regulation of estrus and ovulation in gilts
08/26/1999WO1999042099A1 Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof
08/26/1999WO1999042098A1 Small molecules that increase the conversion of food to body weight gain
08/26/1999WO1999042097A1 Small molecules that elicit a polarized th1 response and for modulation of cellular immunity
08/26/1999WO1999042088A2 Method for the treatment of diseases or disorders of the inner ear
08/26/1999WO1999042085A1 Erythropoietin liposomal dispersion
08/26/1999WO1999042077A2 Compositions and methods for regulating lymphocyte activation
08/26/1999WO1999042076A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/26/1999WO1999042075A2 Antibodies against human cd40
08/26/1999WO1999042001A1 Calorically dense nutritional composition
08/26/1999WO1999041985A1 P53-dependent secretion of growth inhibitory factors
08/26/1999WO1999041984A1 INTERACTION BETWEEN THE MEC1-DEPENDENT DNA SYNTHESIS CHECKPOINT AND G1 CYCLIN FUNCTION IN $i(SACCAROMYCES CEREVISIAE)
08/26/1999WO1999041978A1 Performance enhancement
08/26/1999WO1999033989A3 Rantes mutants and therapeutic applications thereof
08/26/1999WO1999032606A3 Neural precursor cells, method for the production and use thereof in neural defect therapy
08/26/1999WO1999031229A3 Peptides and nucleic acids derived from eisenia foetida and the use thereof
08/26/1999WO1999031136A3 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
08/26/1999WO1999029906A3 Gene family with transformation modulating activity
08/26/1999WO1999029844A3 Novel retroelements zam and idemfix, and their integrase
08/26/1999WO1999029732A3 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
08/26/1999WO1999029714A3 Organic chemical compounds and method for producing the same
08/26/1999WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/26/1999WO1999028342A3 Low-voltage activated calcium channel compositions and methods
08/26/1999WO1999027954A3 Mixed lipopeptide micelles for inducing an immune response
08/26/1999WO1999027094A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
08/26/1999WO1999025375A3 DIRECT CYTOTOXIC ACTIVITY BY ANTI-hCG MONOCLONAL ANTIBODIES
08/26/1999WO1999024571A3 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
08/26/1999WO1999024462A3 Novel conjugates of rgd-containing peptides and endogenous carriers
08/26/1999WO1999023113A3 Rho family antagonists and their use to block inhibition of neurite outgrowth
08/26/1999WO1999006428A9 Tango-72 and tango-77 nucleic acid molecules and polypeptides
08/26/1999WO1999004265A3 Cancer associated nucleic acids and polypeptides
08/26/1999WO1998030696A8 Secreted proteins and polynucleotides encoding them
08/26/1999WO1998004693A3 Secreted proteins and polynucleotides encoding them
08/26/1999DE19909251A1 Agents for treating human diseases, particularly cancer, modulate interaction of beta-catenin with transcription factors or tumor suppressor gene products
08/26/1999DE19810998C1 New metal-containing ribonucleotide proteins with nuclease and phosphatase activities, used e.g. for cell-selective inhibition of protein synthesis and inhibition of tumors
08/26/1999DE19807972A1 New stable, water soluble calcium salts of cyclic lipopeptide antibiotics, useful as antibacterial agents
08/26/1999DE19807265A1 New adenoviral vector useful for gene therapy
08/26/1999CA2687533A1 Immunological methods to modulate myostatin in vertebrate subjects
08/26/1999CA2357015A1 Agents for treating human illnesses based on .beta.-catenin, and the production and use thereof
08/26/1999CA2337638A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/26/1999CA2322617A1 Compounds and methods for diagnosis of tuberculosis
08/26/1999CA2322200A1 Receptor derived peptides as modulators of receptor activity
08/26/1999CA2321961A1 Novel disulfides and thiol compounds
1 ... 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 ... 3163